Iomeron

Iomeprol, the active ingredient in Iomeron, is a iodinated contrast media presented as a solution for injection for intraarterial, intraarticular, and intravenous use. It enhances radiographic imaging of vascular and joint structures in patients undergoing angiography, arthrography, CT, or other diagnostic procedures. It is marketed in the European Union and conforms to EU pharmacopoeial standards.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, imaging centres, diagnostic laboratories, and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Iomeron (iomeprol) is an iodinated contrast agent used to improve radiographic visualization of vascular and joint structures. - Angiography: Provides high‑contrast images of blood vessels to support diagnosis and interventional procedures. - Arthrography: Enhances joint space visualization, facilitating assessment of cartilage, ligaments, and intra‑articular pathology. - CT imaging: Increases tissue attenuation differences, allowing detailed cross‑sectional images of organs and vessels. - Vascular imaging: Improves delineation of arterial and venous anatomy during fluoroscopic and CT angiographic studies.

Iomeron may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Warm sensation or flushing: transient feeling of heat during injection. - Nausea or vomiting: mild gastrointestinal upset that usually resolves quickly. - Urticaria or mild skin rash: temporary itching or hives.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response that can be life‑threatening. - Acute renal impairment: sudden decrease in kidney function, particularly in patients with pre‑existing renal disease. - Severe hypotension or shock: marked drop in blood pressure requiring medical intervention.

Prior to administering Iomeron, several precautionary measures should be observed to minimize risk. - Assess renal function: evaluate serum creatinine and eGFR before use. - Review allergy history: check for prior reactions to iodinated contrast or iodine‑containing substances. - Use lowest effective dose: tailor volume to the specific imaging study. - Monitor vital signs: observe blood pressure, heart rate, and oxygen saturation during and after injection. - Avoid in known iodine hypersensitivity: contraindicated in patients with documented severe allergy to iodinated agents. - Store at ambient temperature: keep in original container, protect from moisture and direct light.

Iomeron can interact with certain medications, affecting safety or efficacy.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents: cumulative iodine load may increase risk of toxicity. - Co‑administration with nephrotoxic drugs (e.g., aminoglycosides, NSAIDs): may exacerbate renal impairment.

Moderate Interactions (Monitor Closely): - Diuretics: may alter renal clearance of the contrast medium, requiring hydration monitoring. - Metformin: in patients with reduced kidney function, temporary discontinuation is advised to prevent lactic acidosis. - Thyroid medications: excess iodine can affect thyroid hormone synthesis, necessitating thyroid function monitoring.